Search results for: Policy Analysis
Filter search results
Drivers of the Growth in Medicines Expenditure
1 October 1997
…the pharmaceutical industry and the Government. The study shows that the position is complex: a number of different forces are at work. Analysis suggests that the largest effect is that…
Trade Mark Legislation and the Pharmaceutical Industry
1 May 1999
…of a trade mark nor the standard economic analysis of its role does much to convey the significance of trade marks in society today. Modern consumers are bombarded with trade…
Biosimilar Competition: Lessons from Europe and Prospects for the US
1 October 2014
Based on an OHE lunchtime seminar by Professor Henry Grabowski, this seminar briefing explores the lessons learned from Europe’s experience with biosimilars, and provides an analysis of how the US…
The Distribution of the EQ-5D-5L Index in Patient Populations
1 October 2016
…the implications of our results for statistical analysis of EQ-5D-5L index data. The results highlight the importance of undertaking careful exploratory data analysis for health related quality of life measures…
Uncertainty and Risk in HTA Decision Making
1 November 2016
…of the policy documents governing cost benefit analysis and cost effectiveness analysis in respect of HTA in England and Wales, and the results of interviews with former decision makers at…
Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets
1 March 2017
Three EQ-5D value sets (the EQ-5D-3L, crosswalk and EQ-5D-5L) are now available for cost utility analysis in the UK and/or England. The value sets’ characteristics differ, and it is important…
Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research
1 August 2018
…out the authors research findings. First, it is possible that some purchasers can introduce health services by improving efficiency rather than displacing an existing activity. Data Envelopment Analysis (DEA) can…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
1 March 2019
…methods alone, but involve political judgements. Two methods are used to explore the marginal relationship between health expenditure and health outcomes: Data Envelopment Analysis (DEA) and Quantile Regression (QR). DEA…
Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
1 January 2020
To date there have been no value sets to support the use of the EQ-5D-Y in cost-utility analysis. Discrete choice experiments (DCEs) can be used to obtain values on a…